Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026)
Hyperfine (HYPR) reported Depreciation & Amortization (CF) of $274000.0 for Q1 2026, up 19.65% on a YoY basis from $229000.0 in Q1 2025, and down 2.49% quarter-over-quarter from $281000.0 in Q4 2025.
Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Hyperfine has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $274000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 19.65% year-over-year to $274000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 16.41% YoY), and the FY2025 full-year result was $1.1 million, up 8.03% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $274000.0, down from $281000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $297000.0 in Q3 2025, with the low at $229000.0 in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $261294.1 across 5 years, with a median of $261000.0 in 2022.
- The largest YoY upside for Depreciation & Amortization (CF) was 163.54% in 2022 against a maximum downside of 22.55% in 2022.
- Hyperfine's Depreciation & Amortization (CF) stood at $261000.0 in 2022, then climbed by 0.77% to $263000.0 in 2023, then decreased by 11.03% to $234000.0 in 2024, then advanced by 20.09% to $281000.0 in 2025, then decreased by 2.49% to $274000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $274000.0 (Q1 2026), $281000.0 (Q4 2025), and $297000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |